Life Sciences

Complying with Massachusetts disclosure regulation will be a challenge

Pharma Compliance Alert, April 1, 2009

Massachusetts’ new disclosure regulation, which goes into effect July 1, presents some unique challenges for pharmaceutical and medical device manufacturers.

“This is the most robust anti-kickback, anti-payment, compliance plan, disclosure, and mandatory set of obligations of this sort anywhere in the country,” says Mark Schreiber, Esq., a partner with Edwards, Angell, Dodge, and Palmer in Boston and head of the firm’s Privacy Group.

Download our free white paper, Massachusetts Disclosure Regulations: New Challenges for Pharmaceutical, Medical Device Manufacturers, to learn more about the new law.